American Diabetes Association
ADA_Diabetic Foot Infections_FIN for Web.pdf (1.08 MB)

Diagnosis and Management of Diabetic Foot Infections

Download (1.08 MB)
Version 2 2020-03-09, 15:09
Version 1 2020-03-09, 14:35
posted on 2020-03-09, 15:09 authored by Ada AdminAda Admin, Andrew J. M. Boulton, Matthew J. Hardman, David G. Armstrong, Matthew Malone, John M. Embil, Christopher E. Attinger, Benjamin A. Lipsky, Javier Aragón-Sánchez, Ho Kwong Li, Gregory Schultz, Robert S. Kirsner
This compendium is a follow-up to the 2018 American Diabetes Association compendium Diagnosis and Management of Diabetic Foot Complications. Whereas the first compendium offered a broad general overview of diabetic foot conditions, this second volume presents a detailed discussion of the prevention and treatment of diabetic foot infections (DFIs), a major contributor to high amputation rates among people with diabetes. The treatise begins from the viewpoint of basic science, describing the impact of infection on the healing process of experimental wounds. There follow overviews of biofilm development in chronic diabetic foot ulcers (DFUs), the microbiology of DFIs, and the crucial role of debridement in ensuring positive outcomes of DFI treatment. Next, the authors provide a practical guide to the diagnosis and clinical management of DFIs. Current controversies regarding the treatment of osteomyelitis are addressed, including the relative value of antibiotics versus surgery and the use of intravenous versus oral antibiotics. The compendium closes with a look at new topical treatments and the role of emerging technologies in infection control.

This publication has been supported by unrestricted educational grants to the American Diabetes Association from Healogics, Inc., and Organogenesis, Inc.

The opinions expressed are those of the authors and do not necessarily reflect those of Healogics, Inc., Organogenesis, Inc., or the American Diabetes Association. The content was developed by the authors and does not represent the policy or position of the American Diabetes Association, any of its boards or committees, or any of its journals or their editors or editorial boards.


Healogics, Inc.

Organogenesis, Inc.